University of Cincinnati doctors test new drug to prevent HIV transmission, battle AIDS' stigma

UC kicked off a multi-year study in March to test a new drug that may prevent the transmission of HIV. Cabotegravir (CAB) could be injected once every two months as an alternative to Truvada, a daily pill that has proven about 90 percent effective in preventing new HIV transmission since the FDA approved its use in 2012.